CNR Institutional Research Information System

COLOMBINO, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.397
NA - Nord America 1.083
EU - Europa 702
SA - Sud America 389
AF - Africa 35
OC - Oceania 2
Totale 4.608
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.019
SG - Singapore 984
CN - Cina 481
BR - Brasile 321
IT - Italia 277
HK - Hong Kong 247
VN - Vietnam 233
BD - Bangladesh 132
FR - Francia 123
NL - Olanda 110
JP - Giappone 108
KR - Corea 70
DE - Germania 42
IN - India 37
GB - Regno Unito 35
CA - Canada 29
AR - Argentina 24
FI - Finlandia 20
AT - Austria 19
ID - Indonesia 15
MX - Messico 15
IE - Irlanda 14
IL - Israele 12
ZA - Sudafrica 12
VE - Venezuela 11
EC - Ecuador 9
PL - Polonia 9
SA - Arabia Saudita 9
IQ - Iraq 8
PH - Filippine 8
RU - Federazione Russa 8
CO - Colombia 7
UA - Ucraina 7
UY - Uruguay 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
PK - Pakistan 6
HN - Honduras 5
TR - Turchia 5
CL - Cile 4
CZ - Repubblica Ceca 4
HU - Ungheria 4
JM - Giamaica 4
KE - Kenya 4
MA - Marocco 4
NP - Nepal 4
TH - Thailandia 4
TN - Tunisia 4
AL - Albania 3
BG - Bulgaria 3
CR - Costa Rica 3
EG - Egitto 3
ES - Italia 3
JO - Giordania 3
LT - Lituania 3
MY - Malesia 3
PT - Portogallo 3
SE - Svezia 3
BO - Bolivia 2
CH - Svizzera 2
DZ - Algeria 2
GE - Georgia 2
GT - Guatemala 2
KZ - Kazakistan 2
LV - Lettonia 2
OM - Oman 2
PY - Paraguay 2
SI - Slovenia 2
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BE - Belgio 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
CU - Cuba 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GF - Guiana Francese 1
GR - Grecia 1
HR - Croazia 1
LB - Libano 1
LK - Sri Lanka 1
LS - Lesotho 1
LU - Lussemburgo 1
MU - Mauritius 1
MW - Malawi 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
VI - Stati Uniti Isole Vergini 1
YE - Yemen 1
Totale 4.608
Salva come PNG Salva come JPEG
Città #
Singapore 560
Santa Clara 278
Hong Kong 246
Hefei 159
San Jose 125
Beijing 105
Lauterbourg 97
Tokyo 95
Ashburn 90
Ho Chi Minh City 90
Seoul 69
Los Angeles 62
Dallas 51
Hanoi 51
São Paulo 35
Cavallino 30
New York 28
Genoa 27
San Gregorio di Catania 23
Buffalo 18
Council Bluffs 17
Amsterdam 16
Cagliari 14
Orem 14
Rome 14
Vienna 14
Dublin 13
Milan 13
Helsinki 12
Da Nang 11
Frankfurt am Main 11
Montreal 11
Mumbai 11
Phoenix 11
Boardman 10
Minamishinagawa 10
Rio de Janeiro 10
Belo Horizonte 9
Johannesburg 9
Chennai 8
Düsseldorf 8
Guangzhou 8
Haiphong 8
Hải Dương 8
Naples 8
Nuremberg 8
Chicago 7
Tashkent 7
Manchester 6
Montevideo 6
Porto Alegre 6
Turku 6
Bari 5
Curitiba 5
Dhaka 5
Maceió 5
Munich 5
Paris 5
Pisa 5
Salvador 5
Seattle 5
Sumaré 5
Toronto 5
Warsaw 5
Araxá 4
Biên Hòa 4
Brooklyn 4
Denver 4
Florence 4
Franca 4
Houston 4
Jeddah 4
London 4
Marseille 4
Mexico City 4
Poplar 4
Quảng Ngãi 4
Quận Một 4
Recife 4
Riyadh 4
Sala Baganza 4
San Francisco 4
Sassari 4
Shanghai 4
Terralba 4
Turin 4
Washington 4
Boston 3
Brescia 3
Buenos Aires 3
Bắc Ninh 3
Caracas 3
Changsha 3
Duque de Caxias 3
Goiânia 3
Ha Long 3
Jakarta 3
Kingston 3
Kyiv 3
Nairobi 3
Totale 2.754
Salva come PNG Salva come JPEG
Nome #
Comparison between Three Different Techniques for the Detection of EGFR Mutations in Liquid Biopsies of Patients with Advanced Stage Lung Adenocarcinoma 119
Four years of activity of the Melanoma Unit of Sassari across North Sardinia 117
Antidiabetic potential of vanadium complexes combined with olive leaf extracts: a viable approach to reduce metal toxicity 78
Il CSCC: aspetti distintivi della patologia 76
Heterogeneous prevalence of mutations in KRAS, BRAF, and PIK3CA genes among Sardinian patients with colorectal carcinoma 74
Multiple primary melanomas from same patients present discrepant somatic alterations in main candidate genes 71
Genetic and molecular alterations in pancreatic cancer progression by next generation sequencing 68
Genetic alterations in main candidate genes during melanoma progression. 67
BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma 67
Microsatellite instability in melanocytic skin lesions (benign nevi, dysplastic nevi, and primary melanomas along with their metastases) 66
nalysis of Fanconi anemia genes in colorectal cancer. 66
Comparison of BRAF Mutation Screening Strategies in a Large Real-Life Series of Advanced Melanoma Patients 64
Dietary compounds and cutaneous malignant melanoma: recent advances from a biological perspective 64
Liquid biopsy in clinical oncology 64
Disease progression and overall survival in Sardinian patients with colorectal cancer according to the kras mutational status 63
Current Trends in Mucosal Melanomas: An Overview 63
Molecular landscape profile of melanoma 62
KIT and PDGFRa mutational patterns in Sardinian patients with gastrointestinal stromal tumors 61
Genetic Instability Markers in Cancer 60
BRAF Mutations and Dysregulation of the MAP Kinase Pathway Associated to Sinonasal Mucosal Melanomas 59
Mutational status of main oncogenes and microsatellite instability in Sardinian patients with advanced colorectal cancer 59
Global prognostic impact of driver genetic alterations in patients with lung adenocarcinoma: a real-life study 58
Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study 57
KRAS mutations in non-small cell lung cancer: Translational aspects, current therapies and challenges for future research 56
Epidemiology and genetic susceptibility of malignant melanoma in North Sardinia, Italy 54
Pattern and distribution of BRAF/NRAS and P16CDKN2A mutations among primary an secondary lesions in melanoma patients [abstract]. 52
Different pathogenetic mechanisms are underlying molecular alterations in fanconi and mismatch DNA repair genes among patients with colorectal carcinoma 51
BRAF testing techniques in the management of patients with advanced malignant melanoma: a real world comparative study 51
Comparison of BRAF testing techniques in patients with advanced malignant melanoma: a real-life study. 51
EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma 51
Are Molecular Alterations Linked to Genetic Instability Worth to Be Included as Biomarkers for Directing or Excluding Melanoma Patients to Immunotherapy? 50
Heterogeneous pathogenesis of melanoma: BRAF mutations and beyond 49
Mutation analysis of candidate genes in melanoma-prone families: Evidence of different pathogenetic mechanisms at chromosome 9P21 48
Mutational Profiles of Cutaneous Squamous Cell Carcinomas with Different Patterns of Clinical Aggression from Head and Neck Regions 47
Assessment of germline and somatic alterations in main candidate genes among patients with multiple primary melanoma 44
Mutations in main candidate genes (egfr, kras, braf) among patients with non-small-cell lung cancer from Sardinia 44
Molecular Pathways in Melanomagenesis: What We Learned from Next-Generation Sequencing Approaches 43
Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI) 42
Vitamin D status and risk for malignant cutaneous melanoma: recent advances 41
Evaluation of genetic heterogeneity in paired lymph node metastases from melanoma patients using next-generation sequencing (NGS) approaches 41
Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanoma 40
Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach 40
Proteomic analysis in melanoma cell lines with different genotypes 39
Prevalence of EGFR, KRAS and BRAF mutations among patients with non-small-cell lung cancer from Sardinia 38
Dermoscopy and confocal microscopy for metachronous multiple melanomas: morphological, clinical, and molecular correlations 38
Comparison of multiple tumor lesions from the same melanoma patients using next-generation sequencing (NGS) approaches 37
Primary Melanoma of the Lung: A Systematic Review 37
Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: A population-based study 36
May genetic background affect the incidence rates of somatic mutations in KRAS, BRAF, and PIK3CA genes among patients with colorectal carcinoma? Clues from Sardinian population 36
Genetic alterations at chromosome 9p21 in primary tumors and metastases from patients with sporadic melanoma: Definition of their clinical significance 34
Impact of tissue type and content of neoplastic cells in the specimen on the quality of epidermal growth factor receptor mutation analysis among patients with lung adenocarcinoma. 34
Prevalence and prognostic role of microsatellite instability in patients with rectal carcinoma 34
Molecular analysis of Fanconi anemia (FA) and mismatch repair (MMR) genes in patients with colorectal carcinoma 33
Identification of predictive factors for the occurrence of predisposing MLH1 and MSH2 germline mutations among Sardinian patients with colorectal carcinoma 32
Molecular analysis of appendiceal mucinous cystadenoma and rectal adenocarcinoma in a patient with urothelial carcinoma: A case report 32
A novel candidate gene in human endometrial cancer at chromosome 10q26 32
CDKN2A mutations could influence the dermoscopic pattern of presentation of multiple primary melanoma: A clinical dermoscopic genetic study 31
DEFINITION OF THE ROLE OF CHROMOSOME 9P21 IN SPORADIC MELANOMA THROUGH GENETIC ANALYSIS OF PRIMARY TUMORS AND THEIR METASTASES 31
Molecular classification for the management of melanoma patients. 30
Prevalence of BRAF and NRAS mutations in primary tumours and different types of metastasis among melanoma patients 30
Assesment of the role of Fanconi Anemia (FA) genes in colorectal cancer: A new pathogenetic pathway? 30
High-resolution methylation analysis of the hMLH1 promoter in sporadic endometrial and colorectal carcinomas 30
Factors predicting the occurrence of germline mutations in candidate genes among patients with cutaneous malignant melanoma from South Italy 30
Mutation analysis of known candidate genes and evaluation of protein expression through proteomic approaches in malignant melanoma 30
Vitamin D status and risk for malignant cutaneous melanoma: recent advances 30
Genetic alterations in main candidate genes during melanoma progression 30
Fanconi genes may contribute to melanoma pathogenesis. 29
Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas 29
BRCA1 and BRCA2 analysis in Sardinian breast cancer families 29
BRAF-NRAS mutation analysis among primary tumors and metastases at different sites from patients with melanoma 29
Low levels of genetic heterogeneity in matched lymph node metastases from melanoma patients 29
Heterogeneous prevalence of somatic mutations in KRAS, BRAF, and PIK3CA genes among patients with colorectal carcinoma: clues from Sardinia 28
Prevalence of KRAS, BRAF, and PIK3CA somatic mutations in patients with colorectal carcinoma may vary in the same population: clues from Sardinia 28
BRCA1 and BRCA2 mutation analysis in breast cancer families from Sardinia 28
Multiple molecular pathways in melanomagenesis: Characterization of therapeutic targets 28
Toward the characterization of a genetic profile with prognostic value at CDKN2A locus in melanoma patients. 27
Loss of Wnt4 and Foxl2 leads to Female-To-Male Sex Reversal Extending to Germ Cells 27
A pattern of polymorphic variants at the CDKN2 locus is associated with both susceptibility and prognosis in melanoma patients. 26
Microsatellite instability and mutation analysis among southern Italian patients with colorectal carcinoma: detection of different alterations accounting of MLH1 and MSH2 inactivation in familial cases 26
Discrepant alterations in main candidate genes among multiple primary melanomas 26
BRAF gene is somatically mutated but does not make a major contribution to malignant melanoma susceptibility: the Italian Melanoma Intergroup study 26
Mutation analysis of candidate genes in familial cases with malignant melanoma: identification of an additional susceptibility region at chromosome 9p21 26
Cytogenetic analysis at chromosome 9p21 on tissue sections from patients with malignant melanoma 26
COX-2 expression positively correlates with PD-L1 expression in human melanoma cells 25
Mutational analysis of candidate genes in families with malignant melanoma (MM): assessment of the role of the CDKN2A gene in MM predisposition. 25
Epidemiological and genetic factors underlying melanoma development in Italy 25
Assessment of genetic instability in melanocytic skin lesions through microsatellite analysis of benign nevi, dysplastic nevi, and primary melanomas along with their metastases. 25
Impact of tissue type and content of neoplastic cells in the specimen on the quality of epidermal growth factor receptor mutation analysis among patients with lung adenocarcinoma. 25
Heterogeneous prevalence of KRAS, BRAF, and PIK3CA mutations in patients with colorectal carcinoma from Sardinia 24
Identification of a novel candidate gene, MENC, in a consensus region of allelic deletion at chromosome 10q26 in human endometrial cancer. 24
Genetic instability and increased mutational load: which diagnostic tool best direct patients with cancer to immuno-therapy? 24
Mutational analysis of candidate genes among patients with malignant melanoma from south Italy. 24
Role on the BRAF gene in malignant melanoma 24
Fanconi genes are altered in subsets of patients with sporadic colorectal carcinoma. 23
Cytogenetic assesment of the involvement of a new locus at 9p21 in malignant melanoma. 23
Epidemiological features and prognostic parameters of multiple primary melanomas in CDKN2A-mutations patients 23
Role of CASC2 a gene in human endometrial cancer. 23
Genetic and epigenetic alterations of mismatch repair genes in endometrial and colorectal carcinomas 23
Mutation analysis of HMLH1-HMSH2 genes among Sardinian patients with sporadic and familial colorectal cancer 23
Transcriptional control of ovarian development in somatic cells 23
Totale 4.165
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.770
article - articoli 12.096
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 574
Totale 28.440
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202417 0 0 0 0 0 0 0 0 2 0 8 7
2024/20251.656 16 7 104 62 290 72 36 90 61 108 419 391
2025/20263.057 124 219 261 383 457 144 440 218 218 243 147 203
Totale 4.730